The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Celecoxib Rowex 200 mg capsules, hard



Rowex LtdPA0711/241/002

Main Information

Trade NameCelecoxib Rowex 200 mg capsules, hard
Active SubstancesCelecoxib
Dosage FormCapsule, hard
Licence HolderRowex Ltd
Licence NumberPA0711/241/002

Group Information

ATC CodeM01AH Coxibs
M01AH01 celecoxib

Status

License statusWithdrawn
Withdrawn Date07/06/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back